DuPont de Nemours, Inc. (DD)
| Market Cap | 17.49B -43.3% |
| Revenue (ttm) | 6.99B +49.3% |
| Net Income | 55.00M |
| EPS | 0.39 |
| Shares Out | 135.04M |
| PE Ratio | 58.80 |
| Forward PE | 17.11 |
| Dividend | $2.40 (1.85%) |
| Ex-Dividend Date | Aug 31, 2026 |
| Volume | 753,263 |
| Open | 130.26 |
| Previous Close | 129.37 |
| Day's Range | 129.02 - 130.80 |
| 52-Week Range | 100.01 - 250.20 |
| Beta | 1.08 |
| Analysts | Buy |
| Price Target | 166.41 (+28.45%) |
| Earnings Date | Nov 3, 2026 |
About DD
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets,... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for DD stock is "Buy." The 12-month stock price target is $166.41, which is an increase of 28.45% from the latest price.
News
DuPont Announces Regular Quarterly Dividend on Common Stock
WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Comm...
DuPont initiated with an Overweight at Barclays
Barclays analyst Aleksey Yefremov initiated coverage of DuPont (DD) with an Overweight rating and $156 price target
DuPont downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Chigusa Katoku downgraded DuPont (DD) to Neutral from Overweight with a price target of $145, down from $172. JPMorgan also removed DuPont from its Analyst Focus List. The…
DuPont price target lowered to $162 from $170 at Citi
Citi analyst Patrick Cunningham lowered the firm’s price target on DuPont (DD) to $162 from $170 and keeps a Buy rating on the shares. The firm adjusted targets in the…
DuPont Schedules Third Quarter 2026 Earnings Conference Call
WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026 financial results at 6:00 a.m.
DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards
Awards recognize continued excellence in healthcare packaging initiatives that utilize Tyvek ® material to help drive and promote sustainable innovation WILMINGTON, Del., Oct. 5, 2026 /PRNewswire/ -- ...
DuPont price target lowered to $172 from $178 at UBS
UBS lowered the firm’s price target on DuPont (DD) to $172 from $178 and keeps a Buy rating on the shares.
DuPont launches Sugar Separation Advisor
DuPont (DD) launched the DuPont Sugar Separation Advisor, an interactive digital tool designed to help sugar and sweetener manufacturers quickly evaluate chromatographic separation potential and ident...
DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification
Digital tool draws on extensive laboratory separation data to help sugar and sweetener producers identify best-fit DuPont™ AmberLite™ chromatography resins for Food & Beverage ingredient applications....
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
A federal judge on Tuesday said more than 20 defendants including 3M , DuPont and Honeywell must face claims by Connecticut firefighters who said their protective gear was contaminated by toxic "fore...
DuPont Launches Tyvek® with Renewable Attribution for Consumer & Industrial Applications
Enabling customers to achieve more sustainable material sourcing without changing how they use Tyvek ® WILMINGTON, Del., Sept. 15, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced the global lau...
Baron & Budd Secures $380 Million Settlement With DuPont, Chemours, and Corteva Over North Carolina PFAS Contamination
DALLAS--(BUSINESS WIRE)--Baron & Budd has secured a $380 million settlement with DuPont, The Chemours Company, and Corteva on behalf of 11 North Carolina public entities to resolve claims arising from...
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
Chemours , DuPont and Corteva on Thursday reached a $455 million settlement with North Carolina and 11 local entities over PFAS contamination claims tied to Chemours' Fayetteville Works plant and ot...
DuPont Chemours and Corteva resolve PFAS-related claims in NC
DuPont (DD) announced that, together with Chemours (CC) and Corteva (CTVA) and its subsidiary EIDP, it has entered into a settlement with the State of North Carolina and 11 local…
Chemours, DuPont and Corteva resolve PFAS claims with $455M settlement
Chemours (CC) announced that, along with DuPont (DD) and Corteva (CTVA), it has entered into a settlement with the State of North Carolina and 11 local entities in the vicinity…
DuPont, Chemours and Corteva Reach Agreement to Resolve PFAS-Related Claims in North Carolina
Resolves litigations brought by the State of North Carolina and 11 local entities relating to PFAS and other historical discharges from Fayetteville Works, as well as the State's claims of PFAS contam...
Flow Cleanrooms & Supply Expands Availability of DuPont™ Tyvek® IsoClean® and Dupont™ Tyvek® 400 Garments
Flow Cleanrooms & Supply expands availability of DuPont™ Tyvek® cleanroom garments for contamination control in critical manufacturing environments.
DuPont Direct Lithium Extraction Team Named 2026 Sustainability Squad by Business Intelligence Group
Recognition highlights the collaborative efforts behind DuPont's recently launched end-to-end direct lithium extraction portfolio, helping accelerate the development of lithium resources needed for el...
Australia's Largest Inland Wastewater Treatment Facility Selects MemCor™ MBR System for Expansion
The Lower Molonglo Water Quality Control Center will become the largest MBR plant in Australia with the addition of a new DuPont™ MemCor™ MBR system WILMINGTON, Del., Aug. 11, 2026 /PRNewswire/ -- DuP...
DuPont price target raised to $172 from $171 at JPMorgan
JPMorgan raised the firm’s price target on DuPont (DD) to $172 from $171 and keeps an Overweight rating on the shares.
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also know...
DuPont price target lowered to $176 from $180 at RBC Capital
RBC Capital analyst Arun Viswanathan lowered the firm’s price target on DuPont (DD) to $176 from $180 and keeps an Outperform rating on the shares.
DuPont Wins R&D 100 Award for Innovation in Healthcare
Award-winning DuPont™ Liveo™ Pharma TPE Ultra-Low Temp Tubing advances biopharma processing applications WILMINGTON, Del., Aug. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has wo...
DuPont Strengthens Corian® Design Distribution Network with Hallmark and Parksite
New distribution alignment improves regional service, increases product availability, and provides continued support for the 2026 Nature in Motion color launch WILMINGTON, Del., Aug. 5, 2026 /PRNewswi...
DuPont price target raised to $178 from $175 at UBS
UBS raised the firm’s price target on DuPont (DD) to $178 from $175 and keeps a Buy rating on the shares.